| Literature DB >> 35991831 |
Fanny Bergeron1, Trana Hussaini2, Natasha Chandok3,4,5, Eric M Yoshida6,7.
Abstract
The regulatory loopholes governing alternative medicine products in Canada represent a public safety issue. In 2017 and 2018, the Liver Transplant Program of the University of British Columbia assessed three patients with acute liver failure secondary to alternative medicines. As health care professionals, we have a duty to both recognize the magnitude of the problem and advocate for reform of the current regulatory process for alternative medicine products.Entities:
Keywords: acute liver injury; alternative medicine; drug-induced liver injury; herbal products; liver transplant; natural health products
Year: 2019 PMID： 35991831 PMCID： PMC9202681 DOI： 10.3138/canlivj.2018-0022
Source DB: PubMed Journal: Can Liver J ISSN： 2561-4444